Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant Features.

copy number variation analysis growing teratoma syndrome methylation classifier multimodal treatment

Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
29 Mar 2024
Historique:
received: 16 02 2024
revised: 19 03 2024
accepted: 28 03 2024
medline: 26 4 2024
pubmed: 26 4 2024
entrez: 26 4 2024
Statut: epublish

Résumé

Molecular analysis of the growing teratoma syndrome has not been extensively studied. Here, we report a 14-year-old boy with a growing mass during treatment for a mixed germ cell tumor of the pineal region. Tumor markers were negative; thus, growing teratoma syndrome was suspected. A radical resection via the occipital transtentorial approach was performed, and histopathological examination revealed a teratoma with malignant features. Methylation classifier analysis confirmed the diagnosis of teratoma, and

Identifiants

pubmed: 38668041
pii: curroncol31040138
doi: 10.3390/curroncol31040138
doi:

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1831-1838

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 21KK0156
Organisme : Japan Society for the Promotion of Science
ID : 20K09384

Auteurs

Daiken Satake (D)

Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Manabu Natsumeda (M)

Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
Advanced Treatment of Neurological Diseases Branch, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Kaishi Satomi (K)

Department of Pathology, Kyorin University Faculty of Medicine, Tokyo 181-8611, Japan.

Mari Tada (M)

Department of Pathology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Taro Sato (T)

Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Noritaka Okubo (N)

Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Keita Kawabe (K)

Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Haruhiko Takahashi (H)

Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Yoshihiro Tsukamoto (Y)

Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Masayasu Okada (M)

Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Masakazu Sano (M)

Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Haruko Iwabuchi (H)

Department of Pediatrics, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.

Nao Shibata (N)

Department of Pediatrics, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.

Masaru Imamura (M)

Department of Pediatrics, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.

Chihaya Imai (C)

Department of Pediatrics, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.
Department of Pediatrics, Toyama University, Toyama 930-0194, Japan.

Hirokazu Takami (H)

Department of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.

Koichi Ichimura (K)

Department of Brain Disease Translational Research, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.

Ryo Nishikawa (R)

Department of Neurosurgery/Neuro-Oncology, Saitama Medical University International Medical Center, Saitama 350-1298, Japan.

Hajime Umezu (H)

Division of Pathology, Niigata University Medical and Dental Hospital, Niigata University, Niigata 951-8520, Japan.

Akiyoshi Kakita (A)

Department of Pathology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Makoto Oishi (M)

Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH